1. Hospital in-patient enquiry. Summary tables,1984
2. Gruppo Italiano per lo nell'Infarto miocardico Studio della Streptochinasi (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction;Lancet,1986
3. Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials;Yusuf, S.; Collins, R.; MacMahon, S.; Peto, R.;Lancet,1988
4. Reduction in major morbidity and mortality by heparin in acute myocardial infarction;MacMahon, S.; Collins, R.; Knight, C.;Circulation,1988
5. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet TIMI Study Group. Comparison 1988; i: 197-203. of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial. NEngl JMed 1989; 320;Simoons, M.L.; Arnold, A.E.R.; Betriu, A.